GLP-1 Agonists
Sort by:
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Primer on Diabetes Management
FEATURING
Silvio Inzucchi
- 39,886 views
- June 16, 2017
- 195
ASPC 2019 Congress on CVD Prevention
Diabetes Treatment Guidelines Finally Have Entered the 21st Century - Almost
FEATURING
Ralph DeFronzo
- 11,582 views
- August 12, 2019
- 58
Robert Busch
GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!
- 7,715 views
- August 14, 2023
- 112
Cardiometabolic Health Congress (CMHC)
SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes
FEATURING
Lance Sloan
- 7,999 views
- June 17, 2019
- 48
Susan Brian
Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist
- 2,149 views
- January 26, 2024
- 40
Susan Brian
The Differences Between the Products of GLP1's and GLP/GIPs
- 2,104 views
- January 29, 2024
- 36
Dr. Sharmila Ghimire
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
FEATURING
Dr. Sharmila Ghimire
- 176 views
- September 13, 2023
- 4
McMaster University Department of Medicine
Semaglutide: Where Are We Now and Where Are We Going?
- 4,129 views
- September 27, 2023
- 23
Emory Diabetes Education Training Academy
Insulin Treatment in Patients with Type 2 Diabetes: When to Use Combination Therapy
FEATURING
Guillermo Umpierrez
- 3,780 views
- May 15, 2020
- 22
Diana Isaacs
Clinical Pearls & Updates on Incretins: The Diabetes Drugs Taking Hollywood by Storm
- 3,383 views
- August 29, 2023
- 19
ACC 2024 Insights
ACC 2024 Insights: Evolving Pharmacology for HFrEF vs. HFpFF - With or Without Chronic Kidney Disease and/or Diabetes
FEATURING
Maria Costanzo
- 1,386 views
- April 16, 2024
- 19
UT Health San Antonio School of Medicine
Effective Treatment of T2DM Requires Combination Therapy
FEATURING
Ralph DeFronzo
- 2,505 views
- August 30, 2023
- 20
The Texas Heart Institute
Inside the Studio w/ Dr. Stephanie Coulter | Dr. Darren McGuire
FEATURING
Stephanie Coulter,
Darren K. Mcguire
- 56 views
- March 10, 2023
- 1
Richard Pratley
Highlights From the 81st ADA Scientific Sessions: The AMPLITUDE Study
- 429 views
- July 23, 2021
- 7
13th Orange County Symposium for Cardiovascular Disease Prevention
SGLT2 inhibitors and GLP-1 agonists: Why Are They Important and Which Do I Choose?
FEATURING
Yehuda Handelsman
- 3,406 views
- January 27, 2022
- 15
Piedmont Heart Institute
Cardiometabolic Therapies: GLP-1 RAs and SGLT-2i
FEATURING
Jaime Burkle
- 1,738 views
- January 25, 2022
- 18
